Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18008241 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Intermittent Preventive Treatment of Malaria in HIV-Seropositive Pregnant Women in Zambia
Conditions: Placental Malaria Infection;   HIV Infections;   Stillbirth;   Prematurity;   Neonatal Deaths
Intervention: Drug: Sulfadoxine-pyrimethamine (Fansidar)

Indicates status has not been verified in more than two years